tiprankstipranks
Century Therapeutics (IPSC)
NASDAQ:IPSC
US Market

Century Therapeutics (IPSC) Financial Statements

117 Followers

Century Therapeutics Financial Overview

Century Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.22; its P/E ratio is -1.13; Century Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 268.00K$ 148.00K$ 99.00K$ 1.72M$ 521.00K
Gross Profit$ 268.00K$ 148.00K$ 99.00K$ 1.72M$ 521.00K
EBIT$ -40.27M$ -32.13M$ -32.20M$ -29.65M$ -32.04M
EBITDA$ -36.72M$ -28.78M$ -28.93M$ -26.69M$ -29.13M
Net Income Common Stockholders$ -39.40M$ -32.72M$ -33.29M$ -31.26M$ -31.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 172.74M$ 169.50M$ 156.40M$ 251.47M$ 315.50M
Total Assets$ 360.69M$ 397.55M$ 417.16M$ 456.23M$ 486.54M
Total Debt$ 46.66M$ 45.53M$ 40.83M$ 51.47M$ 48.94M
Net Debt$ -126.08M$ -123.97M$ -115.56M$ -200.00M$ -266.56M
Total Liabilities$ 175.94M$ 178.32M$ 169.59M$ 179.05M$ 183.81M
Stockholders Equity$ 184.75M$ 219.23M$ 247.57M$ 277.18M$ 302.74M
Cash Flow-
Free Cash Flow$ -27.21M$ -16.91M$ -23.75M$ -34.21M$ -29.18M
Operating Cash Flow$ -26.23M$ -13.65M$ -19.25M$ -29.22M$ -22.91M
Investing Cash Flow$ 18.60M$ 4.22M$ 6.97M$ 31.34M$ -4.27M
Financing Cash Flow$ -356.00K$ 300.00K$ -10.12M$ 448.00K$ 95.00K
Currency in USD

Century Therapeutics Earnings and Revenue History

Century Therapeutics Debt to Assets

Century Therapeutics Cash Flow

Century Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis